WASHINGTON, DC – Dr. Vinay Prasad, the polarizing official who led U.S. vaccine oversight under the Trump administration, has stepped down from his position at the Food and Drug Administration (FDA) ...
The FDA's vaccine chief is set to leave the agency by the end of April, a spokesperson with the Department of Health and Human Services confirmed to ABC News. Dr. Vinay Prasad, the director of the ...
The head of the US Food and Drug Administration’s division of vaccines and gene therapies is leaving the agency after a tumultuous tenure, sending biotech shares higher in late trading on Friday.
WASHINGTON — The Food and Drug Administration's embattled vaccine chief, Dr. Vinay Prasad, is once again leaving the agency — the second time in less than a year that he's departed after controversial ...
The controversial head of the U.S. Food and Drug Administration's vaccines and biologics unit, Dr. Vinay Prasad, will leave the agency at the end of April. FDA commissioner Dr. Marty Makary posted ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
Is the White House putting a leash on Food and Drug Administration vaccine chief Vinay Prasad? Americans can hope so after the agency on Wednesday walked back Dr. Prasad’s startling summary refusal ...
Vinay Prasad, the Trump administration’s top vaccine regulator at the Food and Drug Administration, single-handedly decided to refuse to review Moderna’s mRNA flu vaccine, overruling agency scientists ...
In this week’s edition of InnovationRx, we look at the FDA’s refusal to review Moderna’s flu vaccine, the healthcare giants on Forbes new Greatest Innovators list, why Garner Health is worth $1.35 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results